FDA warning letters
A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.
1,276 letters match. Newest first.
-
DrugsDeqing Jiarou Daily Chemical Co., Ltd.
Deqing Jiarou failed current good manufacturing practice (CGMP) for OTC hand sanitizer, including no methanol testing of ethanol.
High risk -
DrugsHigley Industries, Inc.
FDA warns Higley Industries over CGMP failures in OTC drug manufacturing, including untested ethanol and glycerin.
High risk -
DrugsSkull Smash LLC
Skull Smash LLC sold unapproved, misbranded ammonia inhalant stimulant drugs online, FDA says.
High risk -
DrugsSpirochaete Research Labs, LLC aka Scitus Laboratory Products
FDA warned Spirochaete Research Labs that its Atomic Rhino smelling-salt products are unapproved and misbranded stimulant drugs.
High risk -
DrugsCosmetic Specialty Labs, Inc.
FDA warned Cosmetic Specialty Labs after an inspection found manufacturing failures in OTC drugs and an unlisted product.
High risk -
DrugsNative Salts LLC
FDA warns Native Salts LLC over unapproved, misbranded ammonia smelling-salt stimulant sold as 'N, Native Salts'.
High risk -
DrugsThai Nakorn Patana Co., Ltd.
FDA warns Thai Nakorn Patana over manufacturing quality violations, including missing identity and strength testing before release of OTC drugs.
High risk -
DrugsInnovative Formulations, LLC dba Insane Labz
FDA says Innovative Formulations, doing business as Insane Labz, sells Wake the Dead Smelling Salts, an unapproved ammonia stimulant drug, online.
High risk -
DrugsBell International Laboratories, Inc.
Bell International Laboratories, an OTC drugmaker, was cited for manufacturing rule violations including missing glycerin DEG/EG testing and inadequate quality oversight.
High risk -
Drugsivsupplyclinic.com
ivsupplyclinic.com sold prescription IV fluids online without prescriptions and with altered labels, FDA says.
High risk -
DrugsColgin, Inc.
FDA warned Colgin that its OTC drug ChigaRid External Analgesic violated manufacturing quality rules, including expired ingredients and missing tests.
High risk -
DrugsLightEyez Limited
LightEyez eye drops sold in the U.S. were contaminated with microbes, and FDA cited unapproved new drug claims for its eye drops.
High risk -
DrugsAmman Pharmaceutical Industries
FDA warned Amman Pharmaceutical Industries after a 2023 inspection found sterile drug manufacturing and data integrity failures.
High risk -
DrugsEzriCare LLC
EzriCare distributed non-sterile Artificial Tears made by a CMO with CGMP violations, linked to a Pseudomonas outbreak.
High risk -
DrugsDelsam Pharma LLC
Delsam Pharma distributed non-sterile, contaminated artificial tears and eye ointment made by its contract manufacturer, FDA found.
High risk -
DrugsSalvacion USA Inc.
FDA warned Salvacion USA that Covixyl Nasal Spray is an unapproved new drug sold with antiviral claims.
High risk -
DrugsSichuan Deebio Pharmaceutical Co. Ltd.
FDA warns Sichuan Deebio Pharmaceutical over API manufacturing and data-integrity failures.
High risk -
DrugsUS Chem Labs
FDA warned US Chem Labs that it sells unapproved and misbranded Semaglutide, Tirzepatide, and Thymalin drugs online.
High risk -
DrugsSynthetix Inc. DBA Helix Chemical Supply
FDA says Synthetix Inc., doing business as Helix Chemical Supply, sold unapproved and misbranded Semaglutide and Tirzepatide drugs online.
High risk -
DrugsGlobal Life Technologies Corp.
FDA warns Global Life Technologies over unapproved Nozin Nasal Sanitizer claims, including infection prevention and inside-nostril use.
High risk -
DrugsNingbo Poplar Daily-Use
FDA warned Ningbo Poplar Daily-Use that its OTC drugs had manufacturing quality failures in testing, component identity checks, and stability data.
High risk -
DrugsMadhu Instruments Private Limited
FDA cites Madhu Instruments in New Delhi for insanitary conditions in sterile drug manufacturing and places it on import alert.
High risk -
DrugsQuVa Pharma, Inc.
FDA warned QuVa Pharma, a sterile drug outsourcing facility in Bloomsbury, NJ, of mold in its cleanest filling area and other CGMP failures.
High risk -
DrugsEhy Holdings, LLC
FDA warned Ehy Holdings over unupdated drug listings for nicotine patches and creams, calling products misbranded.
Low -
DrugsLes Importations Herbasanté Inc.
Canadian contract maker of homeopathic drugs, including children's products, skipped ingredient testing and process validation, FDA says.
High risk -
DrugsNantong Furuida Packaging Products Co., Ltd.
Nantong Furuida, an over-the-counter drug manufacturer, failed required manufacturing controls and methanol checks, leading to an FDA import alert.
High risk -
DrugsS & J International Enterprises Public Company Limited
FDA cited S & J International Enterprises for CGMP violations, data integrity failures, and limiting access to records during a drug inspection.
High risk -
DrugsSambrosa Care Inc.
FDA warns Sambrosa Care that its OTC sweet dreams Night Syrup is an unapproved, misbranded drug with excessive doxylamine dosing.
High risk -
DrugsMei Lan Thailand Co., Ltd.
Mei Lan Thailand, an API drug manufacturer, refused an FDA inspection and was placed on Import Alert 55-03.
High risk -
DrugsGlicerinas Industriales, S.A. de C.V.
FDA warned Glicerinas Industriales over CGMP failures in repackaged glycerin and propylene glycol, including DEG/EG testing and particulate contamination.
High risk -
DrugsPrime Lab LLC
Prime Lab LLC failed U.S. drug manufacturing quality rules for over-the-counter hand soaps and sanitizers, including raw-material testing and shared toxic equipment.
High risk -
DrugsWoorilife & Health
Woorilife & Health, a South Korean OTC drug maker, failed to test high-risk ingredients for DEG/EG and lacked quality-unit oversight.
High risk -
DrugsJeffrey W. Taub, M.D./Children's Hospital of Michigan
FDA warns Detroit investigator over pediatric drug trial protocol deviations and lapsed IRB approval.
High risk -
Drugswww.trinexpharmacy.com
FDA warned trinexpharmacy.com for selling unapproved tramadol and misbranded Adderall without prescriptions to U.S. consumers.
High risk -
DrugsCurexa – East, LLC dba Curexa
Curexa - East made compounded drugs under insanitary conditions, with contamination and inadequate cleaning, FDA says.
High risk -
DrugsInopak, Ltd.
Inopak, Ltd. was warned of CGMP (current good manufacturing practice) violations after inspection: poor quality oversight of contract-made hand sanitizer and missing stability testing.
High risk -
DrugsEast Fork Cultivars
East Fork Cultivars sold CBD products as unapproved drugs with COVID-19 and disease-treatment claims, FDA says.
High risk -
DrugsWipro Unza Singapore Private, Limited
FDA cites Wipro Unza Singapore for refusing OTC hand sanitizer records, leading to import alert.
High risk -
DrugsBotanical Be
FDA says Botanical Be sold three pain products containing hidden diclofenac, an unapproved drug, and made drug claims.
High risk -
DrugsHua Da Trading, Inc.
FDA warned Hua Da Trading over WeFun, an unapproved drug sold as a supplement that contains undeclared sildenafil.
High risk -
DrugsAmazon.com, Inc.
FDA warned Amazon that energy supplements sold on its site contained undeclared sildenafil or tadalafil, making them unapproved and misbranded drugs.
High risk -
DrugsPatcos Cosmetics Pvt. Ltd.
Patcos Cosmetics, an Indian OTC drug maker, failed to test high-risk ingredients for DEG/EG and lacked quality-unit oversight.
High risk -
DrugsOmeza LLC
FDA warned Omeza LLC over mold, insects and animal waste in drug manufacturing areas and unapproved nonprescription drugs.
High risk -
DrugsAnish S. Shah, M.D./Siyan Clinical Research
FDA warned clinical investigator Dr. Anish Shah that he broke blinding rules in a depression drug study, calling the site's data into question.
Medium -
DrugsDextrum Laboratories Inc.
FDA found Dextrum Laboratories, an over-the-counter drug contract manufacturer, failed identity testing, toxic glycol checks, water monitoring, and process validation.
High risk -
DrugsColonial Dames Company, Ltd
FDA warns Colonial Dames of manufacturing violations and unapproved acne drug claims for Oxygenetix.
High risk -
DrugsSudesan Temizlik Urunleri Ve Ambalaj Sanaryi Ticaret Anomin Sirketi
FDA warns Turkish hand sanitizer maker Sudesan of CGMP violations and adulterated drugs.
High risk -
DrugsNovid Group, Inc.
FDA told Novid Group its OTC nasal spray, novid NASAL SPRAY, is an unapproved new drug and misbranded.
High risk -
DrugsBelmont Eyecare LLC
FDA warned Belmont Eyecare that its website sells unapproved new drug eye drops with treatment claims.
High risk -
DrugsDr. Berne’s Whole Health Products
Dr. Berne’s MSM eye drops and mist are unapproved new drugs; a tested lot had microbial contamination.
High risk